8-K current report · filed Oct 21, 2026

Medline Inc (MDLN) 8-K Current Report: October 21, 2026

Item 7.01MDLN overview

Short answer

Medline Inc (MDLN) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 7.01 (Regulation FD Disclosure). Voluntary exit from all Medline Brand beds and related products, eliminating a Front Line Care product line.

Medline Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Voluntary exit from all Medline Brand beds and related products, eliminating a Front Line Care product line
  • Affected products generated approximately $60 million in sales over the twelve months ended June 27, 2026
  • Estimated field-action costs up to $220 million, including inventory impairment, disposal costs, and customer credits
  • Costs expected in 2026 and 2027, excluded from Adjusted EBITDA
  • No material fiscal 2026 impact expected, including no change to guidance as of August 5, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Medline Inc 8-K filings

Get the next MDLN 8-K as it lands

Follow MDLN for push alerts, or ask the research agent what this filing means.